Amarin Corporation plc Stock Analysis & AI Score
Amarin Corporation plc (AMRN) has an ST Score of 38.0 (C), driven by its Valuation (A) and held back by its Momentum (D-). Analysts rate it Hold with a $2.17 price target (-83.8% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Amarin Corporation plc (AMRN) has an ST Score of 38.0 (C), driven by its Valuation (A) and held back by its Momentum (D-). Analysts rate it Hold with a $2.17 price target (-83.8% downside).
- Strongest
- ValuationA
- Weakest
- MomentumD-
All factor grades
- ValuationA
- Financial StrengthA-
- GrowthC
- ForecastD
- ProfitabilityD-
- MomentumD-
- Piotroski3/9
Contact
AMRN stock: frequently asked questions
What is AMRN's ST Score?
Amarin Corporation plc (AMRN) has an ST Score of 38.0 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is AMRN a buy, hold, or sell?
Analysts rate AMRN a Hold, with a price target of $2.17 (-83.8% vs the current price). Our ST Score grades it C (38.0/100). The ST Score is a data-driven signal, not a recommendation.
What are AMRN's factor grades?
Valuation A, Profitability D-, Financial Strength A-, Momentum D-, Growth C, Forecast D.
What is AMRN's valuation grade?
Amarin Corporation plc (AMRN) earns a valuation grade of A, measured against Drug Manufacturers - General peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is AMRN's growth grade?
Amarin Corporation plc (AMRN) earns a growth grade of C, measured against Drug Manufacturers - General peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is AMRN's profitability grade?
Amarin Corporation plc (AMRN) earns a profitability grade of D-, measured against Drug Manufacturers - General peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is AMRN's financial strength grade?
Amarin Corporation plc (AMRN) earns a financial strength grade of A-, measured against Drug Manufacturers - General peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for AMRN?
The average analyst price target for Amarin Corporation plc (AMRN) is $2.17 from 18 analysts, which is -83.8% versus the recent price of $13.43.
What is AMRN's Piotroski score?
Amarin Corporation plc (AMRN) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.